Navigation Links
Federal Ethicon Trial Scheduled to Begin at the End of August in U.S. District Court, Southern District of West Virginia, Bernstein Liebhard LLP Reports
Date:8/14/2014

New York, NY (PRWEB) August 14, 2014

A bellwether trial in the federal Ethicon mesh litigation is scheduled to begin at the end of August in the U.S. District Court, Southern District of West Virginia, where thousands of transvaginal mesh lawsuits (http://www.injurybeacon.com/transvaginal-mesh/) are continuing to move forward, Bernstein Liebhard LLP reports.

According to court documents, the hearing will begin on August 25th, 2014, and will involve a woman who was allegedly injured by an implant marketed by the Johnson & Johnson subsidiary, Ethicon, Inc.
The outcome of this case will hopefully serve as an indicator of how future juries will rule in similar actions against the company. Court records indicate that over 21,000 lawsuits have now been filed over Ethicon mesh products in the Southern District of West Virginia. (In re: Ethicon, Inc., Pelvic Repair Systems Products Liability Litigation - MDL No. 2327)

“We are looking forward to the federal Ethicon litigation’s upcoming trial, as our Firm continues to hear from numerous women who were allegedly injured by transvaginal mesh,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free and confidential case evaluations to women who allegedly suffered serious injuries caused by products manufactured by Ethicon and other manufacturers.

Ethicon Mesh Litigation

Ethicon mesh lawsuits in the U.S. District Court, Southern District of West Virginia allege chronic pain, mesh erosion, organ damage and other complications stemming from use of the implants. Jeffrey S. Grand, a partner at Bernstein Liebhard LLP, is serving as on the Plaintiffs’ Steering Committee in the proceeding, which involves claims that Ethicon failed to adequately warn women about these risks in their marketing of the devices. The implants were defectively designed and inadequately tested prior to entering the U.S. market, plaintiffs similarly allege.

In addition to his work in the federal Ethicon mesh litigation, Mr. Grand is also serving on the Plaintiffs’ Steering Committee in several other proceedings in the U.S. District Court, Southern District of West Virginia. These litigations include: American Medical Systems, Inc. (MDL No. 2325); Boston Scientific Corp., (MDL No. 2326); and C.R. Bard, Inc., (MDL No. 2187).

Mr. Grand has also been appointed Co-Liaison Counsel in two vaginal mesh proceedings involving Ethicon and C.R. Bard in New Jersey’s Atlantic County Superior Court. Last year, he served as a member of the Plaintiffs’ trial team for the first trial in the Ethicon proceeding, which ended in March 2013 with an $11 million damage award to the plaintiff. This case involved a woman who suffered transvaginal mesh complications that occurred after receiving an Ethicon Gynecare Prolift implant. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10; In re: Pelvic Mesh Litigation/Bard, No. L-6339-10)

Women who were allegedly injured by transvaginal mesh marketed by Ethicon or another company may be eligible to file a lawsuit that seeks compensation for lost wages, out-of-pocket medical expenses, pain and suffering and other damages. Visit Bernstein Liebhard LLP’s website to learn more about the ongoing transvaginal mesh litigations, or visit the Firm’s Facebook page: https://www.facebook.com/meshlawsuit. To obtain a free, confidential and no-obligation case review, please call 800-511-5092.

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.injurybeacon.com/
https://plus.google.com/115936073311125306742?rel=author

Read the full story at http://www.prweb.com/releases/ethicon-mesh-lawsuit/transvaginal-mesh-lawsuit/prweb12096073.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. The US Department of Justice Involved In A Whistleblower Lawsuit That Alleges Symantec Overcharged Federal and State Governments Tens of Millions Parker Waichman Comments
2. Partner Kristine Kraft Appointed to the Plaintiffs’ Steering Committee (PSC) in Federal Testosterone Replacement Therapy MDL, Schlichter, Bogard & Denton, LLP Reports
3. A Federal Appeals Court Overturned A Prior Ruling That Prevented Some WTC Cleanup Workers From Pursuing Undiagnosed Injury Claims, Parker Waichman LLP Comments
4. Lipitor Lawsuit News: Bernstein Liebhard LLP Notes Growing Number of Type 2 Diabetes Claims in Federal Lipitor Litigation
5. Federal Drug Discount Program faces challenges, report finds
6. DePuy Pinnacle Lawsuit News: New Pretrial Report Issued in Federal Pinnacle Hip Litigation, Bernstein Liebhard LLP Reports
7. Ethicon Transvaginal Mesh Lawsuit News: New Order Issued in Federal Litigation for Second Round of Bellwether Trials, Bernstein Liebhard LLP Reports
8. Byetta Lawsuit News: New Order Establishes Deposition Protocol For Federal Incretin Mimetics Litigation, Bernstein Liebhard LLP Reports
9. C.R. Bard Vaginal Mesh Lawsuits Move Forward, With Issuance of New Pretrial Order in Federal Multidistrict Litigation, Bernstein Liebhard LLP Reports
10. Tylenol Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Upcoming Conference in Federal Tylenol Liver Damage Litigation
11. Risperdal Lawsuits Mount, With Filing of New Gynecomastia Complaint in New York Federal Court, Bernstein Liebhard LLP Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... (PRWEB) , ... June 27, 2016 , ... Quality metrics ... yet in many ways they remain in the eye of the beholder, according to ... a publication of The American Journal of Managed Care. For the full issue, ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand ... project," said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s ... within Final Cut Pro X . Simply select a ProHand generator and drag ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: